 | • レポートコード：GIR-105X17333 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、テノホビルジソプロキシルフマル酸塩のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。テノホビルジソプロキシルフマル酸塩の種類別市場規模（30個/箱、10個/箱）、用途別市場規模（HIV-1感染症、慢性肝炎、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・テノホビルジソプロキシルフマル酸塩の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Glaxo SmithKline、Gilead PHARMACARE、Chengdu Brilliant Pharmaceutical、CHIA TAI TIANQING (CTTQ) Pharmaceutical、Anhui Biochem Pharmaceutical、Qilu Pharmaceutical、Cipla、Zydus Cadila、Dr Reddy's Laboratories、Mylan Pharmaceuticals、Natco Pharma、Emcure Pharmaceuticals、Torrent Pharmaceuticals、Wockhardt Ltd、Hetero Drugs、Abbott ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：30個/箱、10個/箱 ・用途別分析2016年-2026年：HIV-1感染症、慢性肝炎、その他 ・テノホビルジソプロキシルフマル酸塩の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・テノホビルジソプロキシルフマル酸塩のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・テノホビルジソプロキシルフマル酸塩のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・テノホビルジソプロキシルフマル酸塩の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・テノホビルジソプロキシルフマル酸塩の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Tenofovir Disoproxil Fumarate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Tenofovir Disoproxil Fumarate size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Tenofovir Disoproxil Fumarate market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Tenofovir Disoproxil Fumarate market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
30 Pcs/Box
10 Pcs/Box
Market segment by Application can be divided into
HIV-1 Infection
Chronic Hepatitis
Other
The key market players for global Tenofovir Disoproxil Fumarate market are listed below:
Glaxo SmithKline
Gilead PHARMACARE
Chengdu Brilliant Pharmaceutical
CHIA TAI TIANQING (CTTQ) Pharmaceutical
Anhui Biochem Pharmaceutical
Qilu Pharmaceutical
Cipla
Zydus Cadila
Dr Reddy’s Laboratories
Mylan Pharmaceuticals
Natco Pharma
Emcure Pharmaceuticals
Torrent Pharmaceuticals
Wockhardt Ltd
Hetero Drugs
Abbott
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Tenofovir Disoproxil Fumarate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tenofovir Disoproxil Fumarate Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 30 Pcs/Box
1.2.3 10 Pcs/Box
1.3 Market Analysis by Application
1.3.1 Overview: Global Tenofovir Disoproxil Fumarate Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 HIV-1 Infection
1.3.3 Chronic Hepatitis
1.3.4 Other
1.4 Global Tenofovir Disoproxil Fumarate Market Size & Forecast
1.4.1 Global Tenofovir Disoproxil Fumarate Sales in Value (2016-2026))
1.4.2 Global Tenofovir Disoproxil Fumarate Sales in Volume (2016-2026)
1.4.3 Global Tenofovir Disoproxil Fumarate Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Tenofovir Disoproxil Fumarate Production Capacity Analysis
1.5.1 Global Tenofovir Disoproxil Fumarate Total Production Capacity (2016-2026)
1.5.2 Global Tenofovir Disoproxil Fumarate Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tenofovir Disoproxil Fumarate Market Drivers
1.6.2 Tenofovir Disoproxil Fumarate Market Restraints
1.6.3 Tenofovir Disoproxil Fumarate Trends Analysis
2 Manufacturers Profiles
2.1 Glaxo SmithKline
2.1.1 Glaxo SmithKline Details
2.1.2 Glaxo SmithKline Major Business
2.1.3 Glaxo SmithKline Tenofovir Disoproxil Fumarate Product and Services
2.1.4 Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Gilead PHARMACARE
2.2.1 Gilead PHARMACARE Details
2.2.2 Gilead PHARMACARE Major Business
2.2.3 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Product and Services
2.2.4 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Chengdu Brilliant Pharmaceutical
2.3.1 Chengdu Brilliant Pharmaceutical Details
2.3.2 Chengdu Brilliant Pharmaceutical Major Business
2.3.3 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
2.3.4 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical
2.4.1 CHIA TAI TIANQING (CTTQ) Pharmaceutical Details
2.4.2 CHIA TAI TIANQING (CTTQ) Pharmaceutical Major Business
2.4.3 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
2.4.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Anhui Biochem Pharmaceutical
2.5.1 Anhui Biochem Pharmaceutical Details
2.5.2 Anhui Biochem Pharmaceutical Major Business
2.5.3 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
2.5.4 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Qilu Pharmaceutical
2.6.1 Qilu Pharmaceutical Details
2.6.2 Qilu Pharmaceutical Major Business
2.6.3 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
2.6.4 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Tenofovir Disoproxil Fumarate Product and Services
2.7.4 Cipla Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Zydus Cadila
2.8.1 Zydus Cadila Details
2.8.2 Zydus Cadila Major Business
2.8.3 Zydus Cadila Tenofovir Disoproxil Fumarate Product and Services
2.8.4 Zydus Cadila Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Dr Reddy’s Laboratories
2.9.1 Dr Reddy’s Laboratories Details
2.9.2 Dr Reddy’s Laboratories Major Business
2.9.3 Dr Reddy’s Laboratories Tenofovir Disoproxil Fumarate Product and Services
2.9.4 Dr Reddy’s Laboratories Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Mylan Pharmaceuticals
2.10.1 Mylan Pharmaceuticals Details
2.10.2 Mylan Pharmaceuticals Major Business
2.10.3 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
2.10.4 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Natco Pharma
2.11.1 Natco Pharma Details
2.11.2 Natco Pharma Major Business
2.11.3 Natco Pharma Tenofovir Disoproxil Fumarate Product and Services
2.11.4 Natco Pharma Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Emcure Pharmaceuticals
2.12.1 Emcure Pharmaceuticals Details
2.12.2 Emcure Pharmaceuticals Major Business
2.12.3 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
2.12.4 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Torrent Pharmaceuticals
2.13.1 Torrent Pharmaceuticals Details
2.13.2 Torrent Pharmaceuticals Major Business
2.13.3 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
2.13.4 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Wockhardt Ltd
2.14.1 Wockhardt Ltd Details
2.14.2 Wockhardt Ltd Major Business
2.14.3 Wockhardt Ltd Tenofovir Disoproxil Fumarate Product and Services
2.14.4 Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Hetero Drugs
2.15.1 Hetero Drugs Details
2.15.2 Hetero Drugs Major Business
2.15.3 Hetero Drugs Tenofovir Disoproxil Fumarate Product and Services
2.15.4 Hetero Drugs Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Abbott
2.16.1 Abbott Details
2.16.2 Abbott Major Business
2.16.3 Abbott Tenofovir Disoproxil Fumarate Product and Services
2.16.4 Abbott Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Tenofovir Disoproxil Fumarate Sales by Manufacturer
3.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Tenofovir Disoproxil Fumarate Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Tenofovir Disoproxil Fumarate
3.4 Market Concentration Rate
3.4.1 Top 3 Tenofovir Disoproxil Fumarate Manufacturer Market Share
3.4.2 Top 6 Tenofovir Disoproxil Fumarate Manufacturer Market Share
3.5 Global Tenofovir Disoproxil Fumarate Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Tenofovir Disoproxil Fumarate Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tenofovir Disoproxil Fumarate Market Size by Region
4.1.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Region (2016-2026)
4.1.2 Global Tenofovir Disoproxil Fumarate Revenue by Region (2016-2026)
4.2 North America Tenofovir Disoproxil Fumarate Revenue (2016-2026)
4.3 Europe Tenofovir Disoproxil Fumarate Revenue (2016-2026)
4.4 Asia-Pacific Tenofovir Disoproxil Fumarate Revenue (2016-2026)
4.5 South America Tenofovir Disoproxil Fumarate Revenue (2016-2026)
4.6 Middle East and Africa Tenofovir Disoproxil Fumarate Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Type (2016-2026)
5.2 Global Tenofovir Disoproxil Fumarate Revenue by Type (2016-2026)
5.3 Global Tenofovir Disoproxil Fumarate Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Application (2016-2026)
6.2 Global Tenofovir Disoproxil Fumarate Revenue by Application (2016-2026)
6.3 Global Tenofovir Disoproxil Fumarate Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Tenofovir Disoproxil Fumarate Sales by Type (2016-2026)
7.2 North America Tenofovir Disoproxil Fumarate Sales by Application (2016-2026)
7.3 North America Tenofovir Disoproxil Fumarate Market Size by Country
7.3.1 North America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2016-2026)
7.3.2 North America Tenofovir Disoproxil Fumarate Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Tenofovir Disoproxil Fumarate Sales by Type (2016-2026)
8.2 Europe Tenofovir Disoproxil Fumarate Sales by Application (2016-2026)
8.3 Europe Tenofovir Disoproxil Fumarate Market Size by Country
8.3.1 Europe Tenofovir Disoproxil Fumarate Sales in Volume by Country (2016-2026)
8.3.2 Europe Tenofovir Disoproxil Fumarate Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Type (2016-2026)
9.2 Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Application (2016-2026)
9.3 Asia-Pacific Tenofovir Disoproxil Fumarate Market Size by Region
9.3.1 Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Tenofovir Disoproxil Fumarate Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Tenofovir Disoproxil Fumarate Sales by Type (2016-2026)
10.2 South America Tenofovir Disoproxil Fumarate Sales by Application (2016-2026)
10.3 South America Tenofovir Disoproxil Fumarate Market Size by Country
10.3.1 South America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2016-2026)
10.3.2 South America Tenofovir Disoproxil Fumarate Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Type (2016-2026)
11.2 Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Application (2016-2026)
11.3 Middle East & Africa Tenofovir Disoproxil Fumarate Market Size by Country
11.3.1 Middle East & Africa Tenofovir Disoproxil Fumarate Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Tenofovir Disoproxil Fumarate Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Tenofovir Disoproxil Fumarate Typical Distributors
12.3 Tenofovir Disoproxil Fumarate Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Tenofovir Disoproxil Fumarate Revenue by Type, (USD Million), 2021-2026
Table 2. Global Tenofovir Disoproxil Fumarate Revenue by Application, (USD Million), 2021-2026
Table 3. Glaxo SmithKline Basic Information, Manufacturing Base and Competitors
Table 4. Glaxo SmithKline Major Business
Table 5. Glaxo SmithKline Tenofovir Disoproxil Fumarate Product and Services
Table 6. Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Gilead PHARMACARE Basic Information, Manufacturing Base and Competitors
Table 8. Gilead PHARMACARE Major Business
Table 9. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Product and Services
Table 10. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Chengdu Brilliant Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Chengdu Brilliant Pharmaceutical Major Business
Table 13. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
Table 14. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. CHIA TAI TIANQING (CTTQ) Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. CHIA TAI TIANQING (CTTQ) Pharmaceutical Major Business
Table 17. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
Table 18. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Anhui Biochem Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Anhui Biochem Pharmaceutical Major Business
Table 21. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
Table 22. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Qilu Pharmaceutical Major Business
Table 25. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
Table 26. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Cipla Basic Information, Manufacturing Base and Competitors
Table 28. Cipla Major Business
Table 29. Cipla Tenofovir Disoproxil Fumarate Product and Services
Table 30. Cipla Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 32. Zydus Cadila Major Business
Table 33. Zydus Cadila Tenofovir Disoproxil Fumarate Product and Services
Table 34. Zydus Cadila Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Dr Reddy's Laboratories Major Business
Table 37. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Product and Services
Table 38. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Pharmaceuticals Major Business
Table 41. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
Table 42. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Natco Pharma Major Business
Table 45. Natco Pharma Tenofovir Disoproxil Fumarate Product and Services
Table 46. Natco Pharma Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Emcure Pharmaceuticals Major Business
Table 49. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
Table 50. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Torrent Pharmaceuticals Major Business
Table 53. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
Table 54. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Wockhardt Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Wockhardt Ltd Major Business
Table 57. Wockhardt Ltd Tenofovir Disoproxil Fumarate Product and Services
Table 58. Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 60. Hetero Drugs Major Business
Table 61. Hetero Drugs Tenofovir Disoproxil Fumarate Product and Services
Table 62. Hetero Drugs Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Abbott Basic Information, Manufacturing Base and Competitors
Table 64. Abbott Major Business
Table 65. Abbott Tenofovir Disoproxil Fumarate Product and Services
Table 66. Abbott Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Tenofovir Disoproxil Fumarate Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 68. Global Tenofovir Disoproxil Fumarate Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Tenofovir Disoproxil Fumarate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Tenofovir Disoproxil Fumarate Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 71. Head Office and Tenofovir Disoproxil Fumarate Production Site of Key Manufacturer
Table 72. Global Tenofovir Disoproxil Fumarate Sales by Region (2016-2021e) & (K Pcs)
Table 73. Global Tenofovir Disoproxil Fumarate Sales by Region (2021-2026) & (K Pcs)
Table 74. Global Tenofovir Disoproxil Fumarate Revenue by Region (2016-2021e) & (USD Million)
Table 75. Global Tenofovir Disoproxil Fumarate Revenue by Region (2021-2026) & (USD Million)
Table 76. Global Tenofovir Disoproxil Fumarate Sales by Type (2016-2021e) & (K Pcs)
Table 77. Global Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (K Pcs)
Table 78. Global Tenofovir Disoproxil Fumarate Revenue by Type (2016-2021e) & (USD Million)
Table 79. Global Tenofovir Disoproxil Fumarate Revenue by Type (2021-2026) & (USD Million)
Table 80. Global Tenofovir Disoproxil Fumarate Price by Type (2016-2021e) & (USD/Pcs)
Table 81. Global Tenofovir Disoproxil Fumarate Price by Type (2021-2026) & (USD/Pcs)
Table 82. Global Tenofovir Disoproxil Fumarate Sales by Application (2016-2021e) & (K Pcs)
Table 83. Global Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (K Pcs)
Table 84. Global Tenofovir Disoproxil Fumarate Revenue by Application (2016-2021e) & (USD Million)
Table 85. Global Tenofovir Disoproxil Fumarate Revenue by Application (2021-2026) & (USD Million)
Table 86. Global Tenofovir Disoproxil Fumarate Price by Application (2016-2021e) & (USD/Pcs)
Table 87. Global Tenofovir Disoproxil Fumarate Price by Application (2021-2026) & (USD/Pcs)
Table 88. North America Tenofovir Disoproxil Fumarate Sales by Country (2016-2021e) & (K Pcs)
Table 89. North America Tenofovir Disoproxil Fumarate Sales by Country (2021-2026) & (K Pcs)
Table 90. North America Tenofovir Disoproxil Fumarate Revenue by Country (2016-2021e) & (USD Million)
Table 91. North America Tenofovir Disoproxil Fumarate Revenue by Country (2021-2026) & (USD Million)
Table 92. North America Tenofovir Disoproxil Fumarate Sales by Type (2016-2021e) & (K Pcs)
Table 93. North America Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (K Pcs)
Table 94. North America Tenofovir Disoproxil Fumarate Sales by Application (2016-2021e) & (K Pcs)
Table 95. North America Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (K Pcs)
Table 96. Europe Tenofovir Disoproxil Fumarate Sales by Country (2016-2021e) & (K Pcs)
Table 97. Europe Tenofovir Disoproxil Fumarate Sales by Country (2021-2026) & (K Pcs)
Table 98. Europe Tenofovir Disoproxil Fumarate Revenue by Country (2016-2021e) & (USD Million)
Table 99. Europe Tenofovir Disoproxil Fumarate Revenue by Country (2021-2026) & (USD Million)
Table 100. Europe Tenofovir Disoproxil Fumarate Sales by Type (2016-2021e) & (K Pcs)
Table 101. Europe Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (K Pcs)
Table 102. Europe Tenofovir Disoproxil Fumarate Sales by Application (2016-2021e) & (K Pcs)
Table 103. Europe Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (K Pcs)
Table 104. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2016-2021e) & (K Pcs)
Table 105. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2021-2026) & (K Pcs)
Table 106. Asia-Pacific Tenofovir Disoproxil Fumarate Revenue by Region (2016-2021e) & (USD Million)
Table 107. Asia-Pacific Tenofovir Disoproxil Fumarate Revenue by Region (2021-2026) & (USD Million)
Table 108. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Type (2016-2021e) & (K Pcs)
Table 109. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (K Pcs)
Table 110. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Application (2016-2021e) & (K Pcs)
Table 111. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (K Pcs)
Table 112. South America Tenofovir Disoproxil Fumarate Sales by Country (2016-2021e) & (K Pcs)
Table 113. South America Tenofovir Disoproxil Fumarate Sales by Country (2021-2026) & (K Pcs)
Table 114. South America Tenofovir Disoproxil Fumarate Revenue by Country (2016-2021e) & (USD Million)
Table 115. South America Tenofovir Disoproxil Fumarate Revenue by Country (2021-2026) & (USD Million)
Table 116. South America Tenofovir Disoproxil Fumarate Sales by Type (2016-2021e) & (K Pcs)
Table 117. South America Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (K Pcs)
Table 118. South America Tenofovir Disoproxil Fumarate Sales by Application (2016-2021e) & (K Pcs)
Table 119. South America Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (K Pcs)
Table 120. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Country (2016-2021e) & (K Pcs)
Table 121. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Country (2021-2026) & (K Pcs)
Table 122. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue by Country (2016-2021e) & (USD Million)
Table 123. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Type (2016-2021e) & (K Pcs)
Table 125. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (K Pcs)
Table 126. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Application (2016-2021e) & (K Pcs)
Table 127. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (K Pcs)
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Tenofovir Disoproxil Fumarate Typical Distributors
Table 131. Tenofovir Disoproxil Fumarate Typical Customers
List of Figures
Figure 1. Tenofovir Disoproxil Fumarate Picture
Figure 2. Global Tenofovir Disoproxil Fumarate Sales Market Share by Type in 2020
Figure 3. 30 Pcs/Box
Figure 4. 10 Pcs/Box
Figure 5. Global Tenofovir Disoproxil Fumarate Sales Market Share by Application in 2020
Figure 6. HIV-1 Infection
Figure 7. Chronic Hepatitis
Figure 8. Other
Figure 9. Global Tenofovir Disoproxil Fumarate Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 10. Global Tenofovir Disoproxil Fumarate Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Tenofovir Disoproxil Fumarate Sales (2016-2026) & (K Pcs)
Figure 31. Global Tenofovir Disoproxil Fumarate Production Capacity (2016-2026) & (K Pcs)
Figure 32. Global Tenofovir Disoproxil Fumarate Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Tenofovir Disoproxil Fumarate Market Drivers
Figure 34. Tenofovir Disoproxil Fumarate Market Restraints
Figure 35. Tenofovir Disoproxil Fumarate Market Trends
Figure 36. Global Tenofovir Disoproxil Fumarate Sales Market Share by Manufacturer in 2020
Figure 37. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Manufacturer in 2020
Figure 38. Tenofovir Disoproxil Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Tenofovir Disoproxil Fumarate Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Tenofovir Disoproxil Fumarate Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Tenofovir Disoproxil Fumarate Sales Market Share by Region (2016-2026)
Figure 42. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Region (2016-2026)
Figure 43. North America Tenofovir Disoproxil Fumarate Revenue (2016-2026) & (USD Million)
Figure 44. Europe Tenofovir Disoproxil Fumarate Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Tenofovir Disoproxil Fumarate Revenue (2016-2026) & (USD Million)
Figure 46. South America Tenofovir Disoproxil Fumarate Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue (2016-2026) & (USD Million)
Figure 48. Global Tenofovir Disoproxil Fumarate Sales Market Share by Type (2016-2026)
Figure 49. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Type (2016-2026)
Figure 50. Global Tenofovir Disoproxil Fumarate Price by Type (2016-2026) & (USD/Pcs)
Figure 51. Global Tenofovir Disoproxil Fumarate Sales Market Share by Application (2016-2026)
Figure 52. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Application (2016-2026)
Figure 53. Global Tenofovir Disoproxil Fumarate Price by Application (2016-2026) & (USD/Pcs)
Figure 54. North America Tenofovir Disoproxil Fumarate Sales Market Share by Country (2016-2026)
Figure 55. North America Tenofovir Disoproxil Fumarate Revenue Market Share by Country (2016-2026)
Figure 56. North America Tenofovir Disoproxil Fumarate Sales Market Share by Type (2016-2026)
Figure 57. North America Tenofovir Disoproxil Fumarate Sales Market Share by Application (2016-2026)
Figure 58. Europe Tenofovir Disoproxil Fumarate Sales Market Share by Country (2016-2026)
Figure 59. Europe Tenofovir Disoproxil Fumarate Revenue Market Share by Country (2016-2026)
Figure 60. Europe Tenofovir Disoproxil Fumarate Sales Market Share by Type (2016-2026)
Figure 61. Europe Tenofovir Disoproxil Fumarate Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Tenofovir Disoproxil Fumarate Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share by Application (2016-2026)
Figure 66. South America Tenofovir Disoproxil Fumarate Sales Market Share by Country (2016-2026)
Figure 67. South America Tenofovir Disoproxil Fumarate Revenue Market Share by Country (2016-2026)
Figure 68. South America Tenofovir Disoproxil Fumarate Sales Market Share by Type (2016-2026)
Figure 69. South America Tenofovir Disoproxil Fumarate Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Tenofovir Disoproxil Fumarate Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Tenofovir Disoproxil Fumarate Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Tenofovir Disoproxil Fumarate Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のフマル酸ジイソステアリル市場 2021：企業別、地域別、種類・用途別 The Diisostearyl Fumarate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 世界のエムトリシタビン/リルピビリン/テノホビルアラフェナミド市場 2021：企業別、地域別、種類・用途別 The Emtricitabine/Rilpivirine/Tenofovir Alafenamide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 世界のテノホビル/アラフェナミド複合薬市場 2021：企業別、地域別、種類・用途別 The Tenofovir/Alafenamide Compound Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界のエファビレンツ/ラミブジン/テノホビル複合薬市場 2021：企業別、地域別、種類・用途別 The Efavirenz/Lamivudine/Tenofovir Compound Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 世界のテノホビル/ラミブジン/アタザナビル/リトナビル併用薬市場 2021：企業別、地域別、種類・用途別 The Tenofovir/Lamivudine/Atazanavir/Ritonavir Combination Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…